Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

Published:2010-01-28 Issue:6 Volume:66 Page:1019-1029
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Lam Elaine T.,Au Jessie L.- S.,Otterson Gregory A.,Guillaume Wientjes M.,Chen Ling,Shen Tong,Wei Yong,Li Xiaobai,Bekaii-Saab Tanios,Murgo Anthony J.,Jensen Rhonda R.,Grever Michael,Villalona-Calero Miguel A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-010-1252-x.pdf

Reference44 articles.

1. Jemal A, Siegel R, Ward E et al (2009) Cancer statistics. CA Cancer J Clin 59:225–249

2. Weir HK, Thun MJ, Hankey BF et al (2003) Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95:1276–1299

3. Sandler A, Gray R, Perry MC et al (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer. N Engl J Med 355:2542–2550

4. Kelly K, Crowley J, Bunn PA Jr et al (2001) Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: a southwest oncology group trial. J Clin Oncol 19:3210–3218

5. Weick JK, Crowley J, Natale RB et al (1991) A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small cell lung cancer: a southwest oncology group study. J Clin Oncol 9:1157–1162

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Purinergic Landscape of Non-Small Cell Lung Cancer;Cancers;2022-04-11

2. Pathogenesis and therapeutic strategy in platinum resistance lung cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2021-08

3. In Silico and Biological Evaluation of N ‐(2‐methoxyphenyl) Substituted Pyrazoles Accessed via a Sonochemical Method;ChemistrySelect;2021-01-26

4. Nanoparticle-based formulation for drug repurposing in cancer treatment;Drug Repurposing in Cancer Therapy;2020

5. Quantitative contributions of processes by which polyanion drugs reduce intracellular bioavailability and transfection efficiency of cationic siRNA lipoplex;Journal of Controlled Release;2018-01